Home

LATEST NEWS FROM NOVARTIS ONCOLOGY

20-Jan-2010

Three new Novartis medicines approved in Japan for patients with type 2 diabetes, high blood pressure and advanced kidney cancer

10-Dec-2009

Further analysis of BIG 1-98 data supports survival advantage for Novartis drug Femara® over tamoxifen in breast cancer patients

Visit our newsroom


View Videos of Novartis Patient Stories

LaDonna Lopossa	Carol Lundin	Suzan M.	John Ivey


learn more ›	learn more ›	learn more ›	learn more ›


learn more ›	learn more ›	learn more ›

SEARCH OUR WEBSITES

Disclaimer: This site is intended to provide information to audiences outside the United States. Please note that not all products listed within this site may be available in all countries. Also, prescribing information and indications for products may differ from country to country, so please consult your local Novartis company for local prescribing and any other information you may be interested in.